What is the best regimen to treat latent tuberculosis infection?

Affiliations

¹ Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London E1 2AT, UK. Electronic address: s.tiberi@qmul.ac.uk.
² Servizio di Epidemiologia Clinica delle Malattie Respiratorie, Istituti Clinici Scientifici Maugeri IRCCS, Tradate, Italy.

Comment

Simon Tiberi et al. Lancet Infect Dis. 2020 Mar.

. 2020 Mar;20(3):263-264.

doi: 10.1016/S1473-3099(19)30627-9. Epub 2019 Dec 19.

¹ Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London E1 2AT, UK. Electronic address: s.tiberi@qmul.ac.uk.
² Servizio di Epidemiologia Clinica delle Malattie Respiratorie, Istituti Clinici Scientifici Maugeri IRCCS, Tradate, Italy.

No abstract available

Comment on

Adverse events in adults with latent tuberculosis infection receiving daily rifampicin or isoniazid: post-hoc safety analysis of two randomised controlled trials.
Campbell JR, Trajman A, Cook VJ, Johnston JC, Adjobimey M, Ruslami R, Eisenbeis L, Fregonese F, Valiquette C, Benedetti A, Menzies D. Campbell JR, et al. Lancet Infect Dis. 2020 Mar;20(3):318-329. doi: 10.1016/S1473-3099(19)30575-4. Epub 2019 Dec 19. Lancet Infect Dis. 2020. PMID: 31866327